Achieve Life Sciences Balance Sheet
NASDAQ: QUITHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Achieve Life Sciences financial position
At the end of fiscal 2025, Achieve Life Sciences reported total assets of $41.8 million, up 8.2% from a year earlier against total liabilities of $20.3 million. Shareholders' equity stood at $21.5 million, or 51.5% of assets. The company held $20.9 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 4.39, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Achieve Life Sciences balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 20.93M | 12.75M | 15.55M | 24.77M | 43.02M | 35.85M | 16.66M | 9.52M | 5.28M | 15.00K |
| Short-Term Investments | 15.47M | 21.61M | — | — | — | — | — | 5.09M | — | 10.23M |
| Receivables | — | — | — | — | — | — | 8.00K | 7.00K | 9.00K | 478.00K |
| Total Current Assets | 39.89M | 36.47M | 16.98M | 27.33M | 44.59M | 36.98M | 17.33M | 15.54M | 5.91M | 18.00K |
| Property, Plant & Equipment | 3.00K | 8.00K | 13.00K | 4.00K | 15.00K | 42.00K | 57.00K | 35.00K | 59.00K | 258.00K |
| Goodwill | 1.03M | 1.03M | 1.03M | 1.03M | 1.03M | 1.03M | 1.03M | 1.03M | 1.03M | 1.03M |
| Intangible Assets | 751.00K | 974.00K | 1.20M | 1.42M | 1.64M | 1.86M | 2.09M | 2.31M | 2.53M | 2.75M |
| Total Assets | 41.79M | 38.63M | 19.37M | 29.97M | 47.52M | 40.30M | 21.08M | 19.08M | 9.89M | 3.81M |
| Accounts Payable | — | 1.95M | 618.00K | 1.66M | 841.00K | 332.00K | 859.00K | 144.00K | 213.00K | 95.00K |
| Total Current Liabilities | 9.08M | 6.68M | 20.81M | 21.60M | 4.55M | 2.94M | 2.87M | 3.27M | 2.01M | 3.07M |
| Total Liabilities | 20.27M | 17.73M | 20.82M | 21.67M | 19.47M | 3.01M | 3.03M | 3.28M | 2.01M | 3.20M |
| Shareholders' Equity | 21.52M | 20.90M | -1.45M | 8.30M | 28.04M | 37.29M | 18.05M | 15.80M | 15.80M | 610.00K |
| Retained Earnings | -260.23M | -205.58M | -165.75M | -135.94M | -93.59M | -60.43M | -45.70M | -25.38M | -12.69M | -2.06M |
| Net Cash (Debt) | 36.40M | 34.36M | 15.55M | 24.77M | 43.02M | 35.85M | 16.66M | 14.60M | 5.28M | 10.24M |
| Shares Outstanding | 53.23M | 34.69M | 21.17M | 17.90M | 9.45M | 6.11M | 1.47M | 6.72M | 1.19M | 21.23K |
This table shows 10 annual periods of Achieve Life Sciences's balance sheet, from FY 2025 back to FY 2016, across 15 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow QUIT's reporting calendar. What is a balance sheet?